Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhys Jones

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
Frontiers in Immunology|December 14, 2018
Dynamics of Colon Monocyte and Macrophage Activation During ColitisGareth-Rhys Jones, Calum C Bain, Thomas M Fenton, et al.
Diabetes, Obesity & Metabolism|October 17, 2025
Evaluation of leptin treatment on maintenance of body weight loss in diet-induced obese miceDanna M Breen, Rocío M Saavedra-Peña, Stephanie Joaquim, et al.
United European Gastroenterology Journal|February 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohortBeatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 2, 2023
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's DiseaseNathan Constantine-Cooke, Karla Monterrubio-Gómez, Nikolas Plevris, et al.
Trials|July 28, 2021
Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trialDakota Rhys-Jones, Rachel E Climie, Paul A Gill, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 22, 2020
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, ScotlandPhilip W Jenkinson, Nikolas Plevris, Mathew Lyons, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's DiseaseNikolas Plevris, James Fulforth, Mathew Lyons, et al.
Thorax|January 6, 2019
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosisProsenjit Dutta, Wendy Funston, Helen Mossop, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2025
Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)-A Randomised, Controlled Crossover Feeding StudyJane E Varney, Daniel So, Peter R Gibson, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
The Potential Role of Gastric Microbiology in Respiratory DiseaseChris Ward, Hafez Al Momani, Melissa J McDonnell, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|December 14, 2018
Dynamics of Colon Monocyte and Macrophage Activation During ColitisGareth-Rhys Jones, Calum C Bain, Thomas M Fenton, et al.
Diabetes, Obesity & Metabolism|October 17, 2025
Evaluation of leptin treatment on maintenance of body weight loss in diet-induced obese miceDanna M Breen, Rocío M Saavedra-Peña, Stephanie Joaquim, et al.
United European Gastroenterology Journal|February 21, 2023
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohortBeatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 2, 2023
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's DiseaseNathan Constantine-Cooke, Karla Monterrubio-Gómez, Nikolas Plevris, et al.
Trials|July 28, 2021
Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trialDakota Rhys-Jones, Rachel E Climie, Paul A Gill, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 22, 2020
Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, ScotlandPhilip W Jenkinson, Nikolas Plevris, Mathew Lyons, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 18, 2020
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's DiseaseNikolas Plevris, James Fulforth, Mathew Lyons, et al.
Thorax|January 6, 2019
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosisProsenjit Dutta, Wendy Funston, Helen Mossop, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2025
Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)-A Randomised, Controlled Crossover Feeding StudyJane E Varney, Daniel So, Peter R Gibson, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
The Potential Role of Gastric Microbiology in Respiratory DiseaseChris Ward, Hafez Al Momani, Melissa J McDonnell, et al.
Pageof 21